Expression and clinical significance of Topo Ⅱα , COX-2 in breast cancer tissues
10.3760/cma.j.issn.1006-9801.2011.02.009
- VernacularTitle:乳腺癌组织中拓扑异构酶Ⅱα和环氧合酶-2的表达及其临床意义
- Author:
Gang XU
;
Zhongfu SHAO
;
Xiaofang DENG
;
Lizhen HE
- Publication Type:Journal Article
- Keywords:
Breast neoplasms;
DNA Topoisomerase Ⅱα;
Cyclooxygenase 2
- From:
Cancer Research and Clinic
2011;23(2):100-102
- CountryChina
- Language:Chinese
-
Abstract:
Objective To explore the expression of Topo Ⅱα and COX-2 in breast cancer tissues and investigate their correlations to clinicopathologic feature of breast cancer. MethodsThe expression of Topo Ⅱα and COX-2 in 50 specimens of breast cancer and their normal tissues were detected by immunohistochemistry. Their correlation to clinicopathologic features of breast cancer were analyzed.ResultsThe positive rates of Topo Ⅱα were 64 % (32/50) and 22 % (11/50) and COX-2 were 68 % (34/50) , 14 %(7/50) in breast cancer and normal tissue (P<0.05). The expression of Topo Ⅱα was correlated to degree of differentiation (P <0.05), not correlated to patient age, tumor size, clinical stage and lymph node metastasis(P >0.05). The expression of COX-2 was correlated to tumor size, degree of differentiation, clinical stage and lymph node metastasis (P <0.05), not correlated to patient age (P >0.05). Conclusion Topo Ⅱα and COX-2 expression can be used as an indicator for predicting the differentiation, infiltration and metastasis characteristics of breast cancer.